| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥304.4B | ¥308.7B | -1.4% |
| Operating Income | ¥19.9B | ¥33.5B | -40.7% |
| Ordinary Income | ¥19.8B | ¥33.6B | -41.2% |
| Net Income | ¥18.4B | ¥23.5B | -21.8% |
| ROE | 3.8% | 5.1% | - |
FY2026 Q3 consolidated results for Nippon Chemical Industrial show revenue of 30.4B yen (YoY -1.4%), operating income of 2.0B yen (YoY -40.7%), ordinary income of 2.0B yen (YoY -41.2%), and net income of 1.8B yen (YoY -21.8%). The company experienced a significant deterioration in profitability despite relatively stable revenue, with operating margin declining to 6.5% from 10.9% in the prior year period. The profit decline was primarily driven by gross margin compression and increased selling, general and administrative expenses relative to revenue. Total assets increased to 78.4B yen from 75.1B yen, while total equity expanded to 48.2B yen from 46.4B yen. The decline in operating income substantially exceeded the revenue decline, indicating operational leverage challenges and margin pressures across the business portfolio.
Revenue of 30.4B yen declined 1.4% YoY, reflecting a modest contraction in top-line performance. The Chemical Products segment generated revenue of 13.5B yen, down 3.0% YoY from 13.9B yen, representing 44.4% of total revenue. The Functional Products segment recorded revenue of 16.0B yen, up 2.3% YoY from 15.6B yen, accounting for 52.5% of total revenue and serving as the primary revenue driver. The Real Estate Leasing segment contributed 0.7B yen, up 2.6% YoY, representing 2.3% of total revenue. The Other segment revenue declined significantly to 0.2B yen from 0.6B yen, down 62.8% YoY, reflecting a shift from bookstore operations to environmental measurement services. The revenue decline was concentrated in the Chemical Products segment, while Functional Products showed resilience with modest growth.
Operating income of 2.0B yen declined 40.7% from 3.4B yen in the prior year period, with operating margin contracting to 6.5% from 10.9%, a deterioration of 4.4 percentage points. Gross profit decreased to 6.2B yen from 8.0B yen, with gross margin declining to 20.3% from 26.0%, indicating significant cost pressures or unfavorable product mix shifts. Selling, general and administrative expenses of 4.2B yen increased in absolute terms and as a percentage of revenue, further compressing operating profitability. The gap between ordinary income of 2.0B yen and operating income of 2.0B yen was minimal, indicating balanced non-operating items. Net financial expenses totaled 0.1B yen in interest costs. Extraordinary items contributed positively to net income with gains of 0.5B yen primarily from fixed asset disposals, offset by losses of 0.2B yen. This non-recurring contribution of approximately 0.3B yen supported net income, which otherwise would have declined more substantially. The company experienced a revenue down, profit down pattern, with profitability declining at a substantially faster rate than revenue due to margin compression and cost structure challenges.
The Chemical Products segment recorded operating profit of 1.1B yen on revenue of 13.5B yen, with operating margin of 8.1%. This represents a significant decline from prior year operating profit of 1.3B yen on revenue of 13.9B yen (margin of 9.2%), with profit declining 15.1% YoY. The Functional Products segment generated operating profit of 0.4B yen on revenue of 16.0B yen, yielding an operating margin of 2.7%. This marks a dramatic deterioration from prior year operating profit of 1.6B yen on revenue of 15.7B yen (margin of 10.3%), representing a 73.0% decline in segment profit despite modest revenue growth. The Functional Products segment is the largest by revenue share at 52.5% and represents the core business, but experienced the most severe profit deterioration. The Real Estate Leasing segment maintained stable profitability with operating profit of 0.4B yen on revenue of 0.7B yen, yielding a margin of 57.1%, consistent with the prior year margin of 58.0%. The material margin differential between segments is notable, with Real Estate Leasing operating at substantially higher margins than the manufacturing businesses. The sharp profit decline in Functional Products despite revenue growth indicates significant cost inflation, operational inefficiencies, or adverse product mix shifts that require management attention.
[Profitability] ROE of 3.8% declined from prior period levels and remains below the company's historical average, reflecting the significant earnings decline. Operating margin of 6.5% deteriorated 4.4 percentage points from 10.9% YoY, representing substantial margin compression. Net profit margin of 6.0% declined from approximately 7.6% in the prior year period. The Dupont decomposition shows ROE of 3.8% comprises net profit margin of 6.0%, asset turnover of 0.388x, and financial leverage of 1.63x. [Cash Quality] Cash and equivalents of 8.6B yen provide coverage of 0.67x against short-term debt of 12.8B yen, indicating modest liquidity cushion. Working capital increased to 10.8B yen, with receivables turnover extending to 80.9 days and inventory turnover lengthening to 152.7 days, both indicating deteriorating working capital efficiency. [Investment Efficiency] Asset turnover of 0.388x reflects moderate asset utilization. Return on invested capital of 2.8% indicates suboptimal capital efficiency and falls below typical cost of capital thresholds. [Financial Health] Equity ratio of 61.5% improved from 61.8% but remains healthy, indicating strong capital adequacy. Current ratio of 148.0% and quick ratio of 127.3% demonstrate adequate short-term liquidity. Interest-bearing debt of 16.1B yen consists primarily of short-term borrowings of 12.8B yen and long-term debt of 3.3B yen, with debt-to-equity ratio of 0.33x remaining conservative.
Cash and deposits increased 9.2B yen YoY to 8.6B yen, though the absolute level provides limited coverage of short-term obligations at 0.67x. The balance sheet indicates working capital expansion with accounts receivable increasing and inventory levels rising, suggesting cash conversion cycle deterioration. Receivables increased alongside revenue stability, indicating collection period extension, while inventory accumulation without corresponding revenue growth suggests demand softness or production timing mismatches. Accounts payable increased 1.1B yen to 4.6B yen, reflecting extended supplier payment terms that partially offset working capital cash consumption. Investment securities increased 1.5B yen to 6.0B yen, indicating capital deployment into financial assets with associated valuation gains reflected in comprehensive income. Long-term borrowings decreased 1.2B yen to 3.3B yen, suggesting debt repayment or refinancing into short-term facilities. Short-term borrowings of 12.8B yen represent significant reliance on short-term funding, with the 79.5% short-term debt ratio indicating potential refinancing risk. The liquidity position remains adequate but not robust, with working capital efficiency deterioration representing a cash generation headwind that requires operational improvement to restore cash flow health.
Ordinary income of 2.0B yen compared to operating income of 2.0B yen indicates minimal net non-operating impact, with financial expenses of approximately 0.1B yen offset by modest financial income. Non-operating items represent less than 1% of revenue and consist primarily of interest expenses and minor investment income. Extraordinary items contributed positively with gains of 0.5B yen primarily from fixed asset disposals and losses of 0.2B yen, resulting in net extraordinary gain of 0.3B yen representing approximately 34.9% of pre-tax income. This elevated proportion of non-recurring items to total earnings raises quality concerns, as recurring operating performance is weaker than reported net income suggests. The significant decline in operating cash generation capacity relative to reported earnings, evidenced by working capital deterioration with receivables and inventory increases, indicates earnings quality challenges. Cash conversion appears impaired with lengthening collection and inventory cycles suggesting that reported profits are not translating efficiently into cash. The reliance on asset disposal gains to support net income sustainability requires monitoring, as such items are inherently non-recurring and may not be available in future periods.
Full-year guidance targets revenue of 40.5B yen (YoY +4.3%), operating income of 3.2B yen (YoY -4.3%), ordinary income of 3.2B yen, and net income of 2.6B yen. Q3 progress rates show revenue achievement of 75.2%, operating income of 62.1%, ordinary income of 61.9%, and net income of 70.6% relative to full-year targets. Revenue progress aligns closely with the standard 75% Q3 benchmark, indicating on-track top-line performance. Operating and ordinary income progress rates of approximately 62% fall significantly below the 75% standard benchmark, indicating a substantial shortfall of approximately 13 percentage points that requires strong Q4 recovery. Net income progress of 70.6% sits modestly below the standard benchmark, benefiting from extraordinary gains that partially offset the operating income shortfall. The guidance implies Q4 operating income of approximately 1.2B yen, which would represent significant sequential improvement from the Q3 run rate and requires margin recovery or seasonal strength to achieve. The company maintained its full-year guidance despite the Q3 underperformance, suggesting management confidence in Q4 recovery drivers. However, the magnitude of improvement required and the operating margin trajectory raise execution risk around the full-year profit targets.
Annual dividend of 60 yen per share is maintained for the full year, consisting of interim dividend of 46 yen and year-end dividend expected at 46 yen based on the total 60 yen guidance. The dividend remains unchanged from prior year levels, demonstrating commitment to shareholder returns despite earnings decline. Payout ratio relative to forecast net income of 2.6B yen and basic EPS guidance of 297.63 yen yields a payout ratio of approximately 20.2%, which appears conservative and sustainable given the earnings level. However, payout ratio based on annualized Q3 net income would be higher at approximately 44.7%, reflecting the earnings decline year-to-date. No share buyback program was disclosed in the available data. The conservative payout ratio provides dividend sustainability even under current depressed earnings, supported by adequate equity base of 48.2B yen and positive net income generation. Cash coverage of dividends depends on operating cash flow recovery, as working capital deterioration currently constrains cash generation despite positive net income.
Profit margin compression risk remains the most critical concern, with operating margin declining 4.4 percentage points to 6.5%. The deterioration stems from gross margin contraction to 20.3% from 26.0% and elevated SG&A expense ratios. Without successful margin recovery initiatives, the company faces continued earnings pressure and potential guidance shortfalls. The Functional Products segment exhibited particularly severe profit decline of 73.0% despite revenue growth, indicating segment-specific cost challenges, competitive pricing pressure, or unfavorable product mix that threatens the core business profitability.
Working capital efficiency deterioration poses significant cash generation risk, with receivables turnover extending to 80.9 days and inventory turnover lengthening to 152.7 days. The combined effect results in working capital of 10.8B yen and cash conversion cycle deterioration that ties up capital and constrains operating cash flow. Continued working capital expansion without revenue growth acceleration would pressure liquidity and require external financing to sustain operations and dividend payments.
Short-term debt refinancing risk warrants monitoring, with short-term borrowings of 12.8B yen representing 79.5% of total interest-bearing debt and 26.6% of total assets. Cash coverage of short-term debt stands at only 0.67x, indicating potential vulnerability if credit markets tighten or lender relationships change. The shift from long-term to short-term debt structure, evidenced by long-term borrowings declining 26.4% to 3.3B yen, increases maturity concentration and refinancing frequency requirements.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of 3.8% falls below the manufacturing industry median of 5.2% for 2025-Q3, placing the company in the lower performance quartile. Operating margin of 6.5% significantly underperforms the industry median of 8.7%, indicating competitive disadvantage or temporary operational challenges. Net profit margin of 6.0% slightly trails the industry median of 6.4%, suggesting relatively aligned but below-median profitability.
Financial Health: Equity ratio of 61.5% compares favorably to the industry median of 63.8%, indicating solid but slightly below-median capitalization. Current ratio of 148.0% falls substantially below the industry median of 283.0%, reflecting higher working capital intensity or different business model characteristics. The company's current ratio remains adequate but indicates more aggressive working capital management or greater reliance on short-term debt than industry peers.
Efficiency: Asset turnover of 0.388x underperforms the industry median of 0.58x significantly, indicating lower asset productivity and suggesting opportunities for improved capital efficiency. Operating working capital turnover of 127.3 days compares unfavorably to the industry median of 108.1 days, confirming the working capital efficiency challenges identified in company-specific analysis. Return on invested capital of 2.8% falls well below the industry median of 6.0%, highlighting substantial capital efficiency underperformance.
Revenue Growth: Revenue decline of 1.4% underperforms the industry median growth of 2.8% by 4.2 percentage points, placing the company in contraction while peers demonstrate modest expansion. The negative growth trajectory suggests market share loss, end-market weakness in served sectors, or company-specific demand challenges.
※ Industry: Manufacturing (100 companies), Comparison: FY2025-Q3 period, Source: Proprietary analysis
Operating margin recovery represents the critical near-term performance driver, requiring successful execution of cost reduction initiatives and gross margin improvement. The 4.4 percentage point margin decline to 6.5% must reverse to achieve full-year guidance and restore profitability to competitive levels. Management's ability to address the severe 73.0% profit decline in the Functional Products segment, despite revenue growth, will determine whether the current margin pressure is temporary or structural.
Working capital management improvement has emerged as the priority operational focus, with receivables and inventory efficiency deteriorating substantially below industry benchmarks. The extension of receivables turnover to 80.9 days and inventory turnover to 152.7 days versus industry medians indicates significant opportunity for cash generation improvement through operational discipline. Successful working capital reduction would enhance cash flow quality, reduce external financing needs, and support dividend sustainability without requiring profit margin expansion.
Balance sheet structure optimization, particularly addressing the 79.5% short-term debt composition, would reduce refinancing risk and improve financial flexibility. The current reliance on short-term borrowings of 12.8B yen with cash coverage of only 0.67x creates vulnerability to credit market conditions. Extending debt maturity profile or reducing absolute debt levels through cash generation would strengthen the financial position and provide greater strategic flexibility for growth investments or shareholder returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.